Lung and pulmonary vascular disease in scleroderma, the role of ...

More documents

Recommendations

Info

Our local practice • Non-progressive limited disease – observation • Slowly progressive disease – pred/AZA – MMF if intolerant of/progresses on AZA • Rapidly progressive disease – pred/pulsed CYC followed by pred/AZA – MMF if intolerant of/progresses on AZA
Overview • Respiratory diseases in CTD • Systemic sclerosis and the lungs • Interstitial Lung Disease (ILD) • Pulmonary Hypertension (PH)
Page 1 and 2: Lung and Pulmonary Vascular disease
Page 3 and 4: Overview • Respiratory diseases i
Page 5 and 6: Respiratory causes of dyspnoea in C
Page 7 and 8: Serological subsets in scleroderma
Page 9 and 10: Interstitial lung disease
Page 11 and 12: Non Specific Interstitial Pneumonit
Page 13 and 14: ILD - role of the Respiratory Physi
Page 15 and 16: Lung function testing • Volumes (
Page 17 and 18: Spirometry 1) Obstructive defect
Page 19 and 20: Lung function patterns SSc-ILD SSc-
Page 23 and 24: HRCT • Very sensitive • Allows
Page 25 and 26: HRCT extent 20% FVC>70% FVC
Page 27: Management • Supportive - Multidi
Page 31 and 32: PH - a syndrome 1. Pulmonary Arteri
Page 33 and 34: PH - role of the Respiratory Physic
Page 35 and 36: Echo as a screening tool? PASP = 4
Page 37 and 38: PAH screening algorithm at Royal Fr
Page 39 and 40: PH - a syndrome 1. Pulmonary Arteri
Page 41: Take home points • SSc can be ass

Lung and pulmonary vascular disease in scleroderma, the role of ...

Create successful ePaper yourself

Delete template?

Save as template?